Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19.

Chew, Kara W; Moser, Carlee; Daar, Eric S; Wohl, David A; Li, Jonathan Z; Coombs, Robert W; Ritz, Justin; Giganti, Mark; Javan, Arzhang Cyrus; Li, Yijia; Choudhary, Manish C; Deo, Rinki; Malvestutto, Carlos; Klekotka, Paul; Price, Karen; Nirula, Ajay; Fischer, William; Bala, Veenu; Ribeiro, Ruy M; Perelson, Alan S; Fletcher, Courtney V; Eron, Joseph J; Currier, Judith S; Hughes, Michael D; Smith, Davey M

Chew, Kara W; Moser, Carlee; Daar, Eric S; Wohl, David A; Li, Jonathan Z; Coombs, Robert W; Ritz, Justin; Giganti, Mark; Javan, Arzhang Cyrus; Li, Yijia; Choudhary, Manish C; Deo, Rinki; Malvestutto, Carlos; Klekotka, Paul; Price, Karen; Nirula, Ajay; Fischer, William; Bala, Veenu; Ribeiro, Ruy M; Perelson, Alan S; Fletcher, Courtney V; Eron, Joseph J; Currier, Judith S; Hughes, Michael D; Smith, Davey M.

Chew KW; Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA, USA. kchew@mednet.ucla.edu.
Moser C; Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Daar ES; Lundquist Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.
Wohl DA; Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
Li JZ; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Coombs RW; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
Ritz J; Department of Medicine, University of Washington, Seattle, WA, USA.
Giganti M; Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Javan AC; Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Li Y; National Institutes of Health, Bethesda, MD, USA.
Choudhary MC; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Deo R; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Malvestutto C; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Klekotka P; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Price K; Ohio State University Wexner Medical Center, Columbus, OH, USA.
Nirula A; Eli Lilly and Company, San Diego, CA, USA.
Fischer W; Eli Lilly and Company, San Diego, CA, USA.
Bala V; Eli Lilly and Company, San Diego, CA, USA.
Ribeiro RM; Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
Perelson AS; UNMC Center for Drug Discovery, University of Nebraska Medical Center, Omaha, NE, USA.
Fletcher CV; Clinical Pharmacology & Pharmacometrics, Jounce Therapeutics, Cambridge, MA, USA.
Eron JJ; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, USA.
Currier JS; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, USA.
Hughes MD; Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
Smith DM; Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA, USA.

Nat Commun ; 14(1): 333, 2023 Jan 19.

Article in English | MEDLINE | ID: covidwho-2228877

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Language: English Journal: Nat Commun Journal subject: Biology / Science Year: 2023 Document Type: Article Affiliation country: S41467-023-35835-3

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google